[Advances in application of small-molecule compounds in neuronal reprogramming]

Area of Science:

• Neuroscience
• Regenerative Medicine
• Biotechnology

Background:

• Neuronal reprogramming converts somatic cells into neurons for central nervous system (CNS) repair.
• Transcription factors are currently used but have limitations like low efficiency and safety concerns (gene instability, mutation).

Purpose of the Study:

• To review the advancements in small-molecule compound-mediated neuronal reprogramming.
• To discuss the application of this technique in CNS regeneration and repair.

Main Methods:

• Review of recent scientific literature on small-molecule compounds for neuronal reprogramming.
• Analysis of studies focusing on the efficacy and safety of small molecules compared to transcription factors.

Main Results:

• Small molecules present advantages over transcription factors in neuronal reprogramming efficiency and safety.
• These compounds can overcome limitations associated with exogenous gene introduction.

Conclusions:

• Small-molecule-mediated neuronal reprogramming is a promising therapeutic strategy for CNS injuries and diseases.
• Further research in this area could lead to effective clinical applications for neurological repair.